Provided by Tiger Trade Technology Pte. Ltd.

BioLine Rx

2.91
+0.306911.80%
Volume:132.08K
Turnover:382.94K
Market Cap:12.65M
PE:-1.58
High:2.91
Open:2.90
Low:2.90
Close:2.60
52wk High:4.56
52wk Low:2.15
Shares:4.35M
Float Shares:4.17M
Volume Ratio:3,366.32
T/O Rate:3.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8408
EPS(LYR):-0.2856
ROE:-46.72%
ROA:-16.55%
PB:0.76
PE(LYR):-10.18

Loading ...

Israel's BioLineRx Q2 Net Loss Widens on Higher R&D Expenses

Reuters
·
2 hours ago

BioLine Rx Q2 Sales $294.000K Miss $500.000K Estimate

Benzinga Earnings
·
2 hours ago

Press Release: BioLineRx Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
2 hours ago

BioLine RX Ltd Expected to Post Breakeven Results a Share - Earnings Preview

Reuters
·
Aug 28

BioLineRx, Hemispherian announces new preclinical data on GLIX1, PARP inhibitor

TIPRANKS
·
Jul 08

JonesTrading Reaffirms Their Buy Rating on Bioline RX Ltd Sponsored ADR (BLRX)

TIPRANKS
·
Jun 02

Analysts Offer Insights on Healthcare Companies: Bioline RX Ltd Sponsored ADR (BLRX), BeOne Medicines (ONC) and Autonomix Medical, Inc. (AMIX)

TIPRANKS
·
Jun 02

BioLine Rx Q1 Sales $477.000K Beat $343.000K Estimate

Benzinga Earnings
·
May 27

Press Release: BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
May 27

BioLine RX Ltd expected to post a loss of $1.04 a share - Earnings Preview

Reuters
·
May 25

BioLineRx and Hemispherian report new GLIX1 anti-tumor effect in GBM

TIPRANKS
·
May 19

BioLine Rx Q4 EPADS $(0.34) Beats $(0.54) Estimate, Sales $194.000K Miss $651.598K Estimate

Benzinga Earnings
·
Mar 24

BioLine Rx Q4 Sales $194.000K Miss $651.598K Estimate

Benzinga Earnings
·
Mar 23

Press Release: BioLineRx Reports 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Mar 23

BioLine RX Ltd expected to post a loss of 77 cents a share - Earnings Preview

Reuters
·
Mar 20

Top Wall Street Forecasters Revamp BioLineRx Expectations Ahead Of Q4 Earnings

Benzinga_recent_news
·
Mar 20

BioLine RX Ltd expected to post a loss of 77 cents a share - Earnings Preview

Reuters
·
Mar 17